Institutions / Avoro Capital Advisors LLC
Avoro Capital Advisors LLC
CIK 1633313 · Institution · as of Dec 31, 2025
Portfolio value
$10.17B
Positions
33
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 33 →
| Company | Value | % of portfolio |
|---|---|---|
| United Therapeutics Corp | $1.27B | 12.5% |
| Ascendis Pharma A/S | $1.09B | 10.7% |
| Madrigal Pharmaceuticals, Inc. | $1.05B | 10.3% |
| Argenx SE | $832.54M | 8.2% |
| Krystal Biotech, Inc. | $712.23M | 7.0% |
| Arrowhead Pharmaceuticals, Inc. | $705.39M | 6.9% |
| Kymera Therapeutics, Inc. | $581.61M | 5.7% |
| Structure Therapeutics Inc.GPCR | $455.94M | 4.5% |
| Avidity Biosciences, Inc. | $393.47M | 3.9% |
| Centessa Pharmaceuticals PLC | $364.03M | 3.6% |
| Celcuity Inc.CELC | $310.30M | 3.1% |
| Apellis Pharmaceuticals, Inc. | $307.02M | 3.0% |
| Vera Therapeutics, Inc. | $298.21M | 2.9% |
| SPDR Series Trust - S&P Biotech | $256.05M | 2.5% |
| Xenon Pharmaceuticals Inc. | $243.12M | 2.4% |
| Terns Pharmaceuticals, Inc. | $175.74M | 1.7% |
| Revolution Medicines, Inc. | $172.84M | 1.7% |
| Uniqure NV | $147.17M | 1.4% |
| Soleno Therapeutics, Inc. | $134.27M | 1.3% |
| Ocular Therapeutix, Inc | $130.84M | 1.3% |
| Taysha Gene Therapies, Inc.TSHA | $119.35M | 1.2% |
| Mind Medicine (Mindmed) Inc | $66.95M | 0.7% |
| PTC Therapeutics Inc | $52.03M | 0.5% |
| Viridian Therapeutics, Inc. | $46.68M | 0.5% |
| Oruka Therapeutics, Inc. | $40.41M | 0.4% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.